Common Contracts
1 similar Purchase and License Agreement contracts
Alexion completes purchase and licence agreement for early-stage rare disease gene therapy portfolio from PfizerPurchase and License Agreement • September 28th, 2023
Alexion, AstraZeneca Rare Disease, has completed a definitive purchase and licence agreement for a portfolio of preclinical rare disease gene therapy programmes and enabling technologies from Pfizer Inc. (Pfizer).
